ARUK-2002821

N/A

Report date: 2023/11/06 14:19:07
NME

Base Information

Drug NameARUK-2002821
Drug Alias NameARUK2002821ARUK-2002821
ClassificationSmall molecules
Mechanisms of ActionPhosphatidylinositol 5-phosphate 4-kinase α inhibitors
TargetsPhosphatidylinositol 5-phosphate 4-kinase α
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCambridge Biomedical Campus
China Registration ClassN/A

Develop Information

Active CompaniesCambridge Biomedical Campus
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A